MapLight Therapeutics, Inc. (MPLT)
30.27
+2.47
(+8.88%)
USD |
NASDAQ |
Jun 11, 16:00
30.27
0.00 (0.00%)
After-Hours: 19:40
MapLight Therapeutics Total Liabilities (Quarterly) : 18.95M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 18.95M |
| December 31, 2025 | 21.14M |
| September 30, 2025 | 23.71M |
| June 30, 2025 | 20.36M |
| Date | Value |
|---|---|
| March 31, 2025 | 18.57M |
| June 30, 2024 | |
| March 31, 2024 | 19.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Mineralys Therapeutics, Inc. | 14.72M |
| Evommune, Inc. | 17.90M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Oncolytics Biotech, Inc. | 13.29M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 418.79M |
| Shareholders Equity (Quarterly) | 399.83M |
| Debt to Equity Ratio | 0.014 |
| Current Ratio | 22.91 |
| Net Debt Paydown Yield | -0.12% |